PROGNOSTIC IMPORTANCE OF DNA FLOW CYTOMETRIC, HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL PARAMETERS IN NEUROBLASTOMAS

被引:10
作者
CARLSEN, NLT
ORNVOLD, K
CHRISTENSEN, IJ
LAURSEN, H
LARSEN, JK
机构
[1] UNIV COPENHAGEN,RIGSHOSP,DEPT PAEDIAT SURG,DK-2100 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,RIGSHOSP,DEPT PAEDIAT PATHOL,DK-2100 COPENHAGEN,DENMARK
[3] UNIV COPENHAGEN,RIGSHOSP,FINSEN LAB,DK-2100 COPENHAGEN,DENMARK
[4] UNIV COPENHAGEN,INST NEUROPATHOL,DK-1168 COPENHAGEN,DENMARK
关键词
IMMUNOHISTOCHEMICAL MARKERS; FLOW CYTOMETRY; PLOIDY; S-PHASE FRACTION; SHIMADA CLASSIFICATION;
D O I
10.1007/BF01600512
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
In 42 tumour samples of human neuroblastoma, histological classification by differentiation (Shimada) was significantly correlated with strong positivity for neuron-specific enolase (NSE) and inversely correlated with rosette formation. Most ganglioneuroblastomas were positive for S-100 protein and reacted strongly with NSE antibody. Histological signs of high proliferative activity included intermediate or high mitosis-karyorrhexis index, necrosis and lack of calcification, which were significantly correlated with each other. Flow cytometric DNA analysis demonstrated that 88% of the tumour samples had DNA aneuploid stem lines. High S phase fraction (greater-than-or-equal-to 0.20) was significantly correlated with necrosis and lack of calcification. Univariate analysis of prognosis for 26 patients whose tumour samples were obtained before adjuvant treatment showed that five factors were significantly related to a better outcome: early stage of the disease (stages I, II, IV-S), S phase fraction < 0.20, favourable Shimada histology, positivity for S-100 protein, and strong positivity for NSE. In multivariate analysis, only S phase fraction or stage of disease remained significantly associated with prognosis. DNA index did not correlate with prognosis in this study.
引用
收藏
页码:411 / 418
页数:8
相关论文
共 64 条
[1]   AUTOLYSIS IS A POTENTIAL SOURCE OF FALSE ANEUPLOID PEAKS IN FLOW CYTOMETRIC DNA HISTOGRAMS [J].
ALANEN, KA ;
JOENSUU, H ;
KLEMI, PJ .
CYTOMETRY, 1989, 10 (04) :417-425
[2]  
ANDERSON JR, 1985, CANCER TREAT REP, V69, P1139
[3]  
AOYAMA C, 1990, CANCER, V65, P255, DOI 10.1002/1097-0142(19900115)65:2<255::AID-CNCR2820650213>3.0.CO
[4]  
2-5
[5]  
Beckwith J B, 1968, J Pediatr Surg, V3, P106
[6]  
BIEDLER JL, 1988, ADV NEUROBLASTOMA RE, V2, P359
[7]  
BOURHIS J, 1991, CANCER RES, V51, P33
[8]   FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT IN CHILDREN WITH NEURO-BLASTOMA [J].
BRENNER, DW ;
BARRANCO, SC ;
WINSLOW, BH ;
SHAEFFER, J .
JOURNAL OF PEDIATRIC SURGERY, 1989, 24 (02) :204-207
[9]  
BRESLOW N, 1971, CANCER RES, V31, P2098
[10]   MOLECULAR-BIOLOGY AND GENETICS OF HUMAN NEURO-BLASTOMA [J].
BRODEUR, GM ;
FONG, CT .
CANCER GENETICS AND CYTOGENETICS, 1989, 41 (02) :153-174